Cargando…
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65–84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701678/ https://www.ncbi.nlm.nih.gov/pubmed/36437298 http://dx.doi.org/10.1038/s41598-022-24409-w |
| _version_ | 1784839586568994816 |
|---|---|
| author | Durier, Christine Ninove, Laetitia Lefebvre, Maeva Radenne, Anne Desaint, Corinne Ropers, Jacques Bauer, Rebecca Lebbah, Said Carette, Diane Lachatre, Marie Lecompte, Anne-Sophie Deplanque, Dominique Botelho-Nevers, Elisabeth Conrad, Anne Dussol, Bertrand Maakaroun-Vermesse, Zoha Melica, Giovanna Nicolas, Jean-François Verdon, Renaud Kiladjian, Jacques Loubet, Paul Schmidt-Mutter, Catherine Dualé, Christian Ansart, Séverine Priet, Stéphane Levier, Axel Molino, Diana Vieillard, Louis-Victorien Parfait, Béatrice Lelièvre, Jean-Daniel Tartour, Eric de Lamballerie, Xavier Launay, Odile |
| author_facet | Durier, Christine Ninove, Laetitia Lefebvre, Maeva Radenne, Anne Desaint, Corinne Ropers, Jacques Bauer, Rebecca Lebbah, Said Carette, Diane Lachatre, Marie Lecompte, Anne-Sophie Deplanque, Dominique Botelho-Nevers, Elisabeth Conrad, Anne Dussol, Bertrand Maakaroun-Vermesse, Zoha Melica, Giovanna Nicolas, Jean-François Verdon, Renaud Kiladjian, Jacques Loubet, Paul Schmidt-Mutter, Catherine Dualé, Christian Ansart, Séverine Priet, Stéphane Levier, Axel Molino, Diana Vieillard, Louis-Victorien Parfait, Béatrice Lelièvre, Jean-Daniel Tartour, Eric de Lamballerie, Xavier Launay, Odile |
| author_sort | Durier, Christine |
| collection | PubMed |
| description | Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65–84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost. |
| format | Online Article Text |
| id | pubmed-9701678 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97016782022-11-28 Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years Durier, Christine Ninove, Laetitia Lefebvre, Maeva Radenne, Anne Desaint, Corinne Ropers, Jacques Bauer, Rebecca Lebbah, Said Carette, Diane Lachatre, Marie Lecompte, Anne-Sophie Deplanque, Dominique Botelho-Nevers, Elisabeth Conrad, Anne Dussol, Bertrand Maakaroun-Vermesse, Zoha Melica, Giovanna Nicolas, Jean-François Verdon, Renaud Kiladjian, Jacques Loubet, Paul Schmidt-Mutter, Catherine Dualé, Christian Ansart, Séverine Priet, Stéphane Levier, Axel Molino, Diana Vieillard, Louis-Victorien Parfait, Béatrice Lelièvre, Jean-Daniel Tartour, Eric de Lamballerie, Xavier Launay, Odile Sci Rep Article Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65–84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost. Nature Publishing Group UK 2022-11-27 /pmc/articles/PMC9701678/ /pubmed/36437298 http://dx.doi.org/10.1038/s41598-022-24409-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Article Durier, Christine Ninove, Laetitia Lefebvre, Maeva Radenne, Anne Desaint, Corinne Ropers, Jacques Bauer, Rebecca Lebbah, Said Carette, Diane Lachatre, Marie Lecompte, Anne-Sophie Deplanque, Dominique Botelho-Nevers, Elisabeth Conrad, Anne Dussol, Bertrand Maakaroun-Vermesse, Zoha Melica, Giovanna Nicolas, Jean-François Verdon, Renaud Kiladjian, Jacques Loubet, Paul Schmidt-Mutter, Catherine Dualé, Christian Ansart, Séverine Priet, Stéphane Levier, Axel Molino, Diana Vieillard, Louis-Victorien Parfait, Béatrice Lelièvre, Jean-Daniel Tartour, Eric de Lamballerie, Xavier Launay, Odile Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years |
| title | Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years |
| title_full | Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years |
| title_fullStr | Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years |
| title_full_unstemmed | Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years |
| title_short | Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years |
| title_sort | neutralizing antibodies against sars-cov-2 variants following mrna booster vaccination in adults older than 65 years |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701678/ https://www.ncbi.nlm.nih.gov/pubmed/36437298 http://dx.doi.org/10.1038/s41598-022-24409-w |
| work_keys_str_mv | AT durierchristine neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT ninovelaetitia neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT lefebvremaeva neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT radenneanne neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT desaintcorinne neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT ropersjacques neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT bauerrebecca neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT lebbahsaid neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT carettediane neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT lachatremarie neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT lecompteannesophie neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT deplanquedominique neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT botelhoneverselisabeth neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT conradanne neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT dussolbertrand neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT maakarounvermessezoha neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT melicagiovanna neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT nicolasjeanfrancois neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT verdonrenaud neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT kiladjianjacques neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT loubetpaul neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT schmidtmuttercatherine neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT dualechristian neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT ansartseverine neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT prietstephane neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT levieraxel neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT molinodiana neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT vieillardlouisvictorien neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT parfaitbeatrice neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT lelievrejeandaniel neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT tartoureric neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT delamballeriexavier neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT launayodile neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years AT neutralizingantibodiesagainstsarscov2variantsfollowingmrnaboostervaccinationinadultsolderthan65years |